Clinical Trials Using Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes

There are no NCI-supported clinical trials studying autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes at this time. You can try a new search or contact our Cancer Information Service to talk about options for clinical trials.